Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Third-party claim

Rules 1.1.0 · as of 14 Sep 2026

Quote

Third-party claim

“As we prepare for the potential commercial launch of COMP360 for treatment-resistant depression, our priority is ensuring that healthcare providers are trained, confident, and ready to deliver COMP360 treatment responsibly where eligible patients may receive care ... ready to deliver psilocybin treatment at scale, if approved.”
· Brain Medicine in The News! · substack post

Quoted statement by Dr. Steve Levine, Chief Patient Officer at Compass Pathways, in the training-grant announcement: Compass is preparing for a potential commercial launch of COMP360 for treatment-resistant depression and wants providers ready to deliver psilocybin treatment at scale if approved.

A quoted or paraphrased claim by someone else that the author does not adopt as their own.